Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)
This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.
Subject has signed a valid, IRB-approved informed consent form, can understand t... [+7]
The subject has an active medical device implant anywhere in the body (including... [+15]